
Home > About Takeda > Overview
Main contents starts here
Takeda is a research-based global pharmaceutical company. As the largest pharmaceutical company in Japan and one of the global leaders of the industry. Setting our management philosophy, " Takeda-ism " as the basis of business, Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products.
Takeda is enhancing its R&D pipeline by concentrating its management resources.
Takeda's in-house ethical drugs are marketed in around 90 countries worldwide and are recognized as the brand in major countries worldwide.
| Company Name | Takeda Pharmaceutical Company Limited |
| Headquarters Head Office | 1-1, Doshomachi 4-chome, Chuo-ku, Osaka 540-8645 TEL: +81 6 6204-2111 FAX: +81 6 6204-2880 |
| Tokyo Head Office | 12-10, Nihonbashi 2-chome, Chuo-ku, Tokyo 103-8668 TEL: +81 3 3278-2111 FAX: +81 3 3278-2000 |
| Founded | June 12, 1781 |
| Incorporated | January 29, 1925 |
| President | Yasuchika Hasegawa |
| Paid-In Capital | ¥63.5 billion |
| Number of Employees | 6,368 (parent), 19,362 (consolidated) |
| Number of Shareholders | 196,437 |
| Scope of Business | Manufacturing, marketing and import / export of pharmaceutical drugs, etc. |
| R&D Facilities | Osaka, Tsukuba (Japan), Palo Alto, San Diego, San Francisco, Deerfield(U.S.), London, Cambridge(U.K.), Singapore |
| Production Facilities | Osaka, Hikari, Italy, Ireland, China, Indonesia |
| Overseas Subsidiaries and affiliates | U.S., Canada, U.K., France, Italy, Germany, Austria, Switzerland, Spain,Portugal, Ireland, Netherlands, China, Taiwan, Philippines, Thailand, Indonesia, Singapore |

| FY 2008 (April 2008 - March 2009) |
FY 2007 (April 2007 - March 2008) |
|
| Net Sales | ¥1,538.3 billion (US$15,697 million) |
¥1,375 billion (US$13,748 million) |
| Net Income | ¥234.4 billion (US$2,392 million) |
¥355.5 billion (US$3,555 million) |
| R&D Investment | ¥453.0billion (US$4,623 million) |
¥275.8billion (US$2,758 million) |
| Earnings Per Share | ¥289.82 (US2.96) |
¥418.97 (US4.19) |
| Dividends Per Share | ¥180.00 (US$1.84) |
¥168.00 (US$1.68) |
| Consolidated Subsidiaries | 49 companies | 47 companies |
| Affiliated Companies Accounted for by the Equity Method |
15 companies | 17 companies |
[*]Note: The U.S. dollar amounts represent translations of Japanese yen, for convenience only, at the rate of ¥98=US$1 for FY 2008 and ¥100=US$1 for FY 2007.


